Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:11:09.637Z.
Calculation as of: 2026-10-06T16:11:09.637Z.
Quote observation: 2026-10-06T16:10:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 370e13d786cc28e63fbc6719e554b7ac483294971c86eef7c80c09e39811c756
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Candel Therapeutics, Inc.
Market Cap
$744.71M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$737.40M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$737.09M
Operating Cash Flow Yield
N/A
TTM Avg
23.08%
3Y Avg
23.11%
5Y Avg
23.11%
Market Cap
$759.48M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$720.94M
Operating Cash Flow Yield
N/A
TTM Avg
4.26%
3Y Avg
2.63%
5Y Avg
1.85%
Market Cap
$717.52M
Operating Cash Flow Yield
N/A
TTM Avg
5.57%
3Y Avg
5.48%
5Y Avg
5.48%
Market Cap
$771.14M
Operating Cash Flow Yield
7.22%
TTM Avg
8.35%
3Y Avg
7.91%
5Y Avg
6.12%
Market Cap
$717.44M
Operating Cash Flow Yield
45.99%
TTM Avg
23.51%
3Y Avg
20.54%
5Y Avg
18.34%
Market Cap
$714.33M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | $744.71M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.40M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $737.09M | N/A | 23.08% | 23.11% | 23.11% |
| Design Therapeutics, Inc. (DSGN)vs › | $759.48M | N/A | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.94M | N/A | 4.26% | 2.63% | 1.85% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $717.52M | N/A | 5.57% | 5.48% | 5.48% |
| Mesa Laboratories, Inc. (MLAB)vs › | $771.14M | 7.22% | 8.35% | 7.91% | 6.12% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $717.44M | 45.99% | 23.51% | 20.54% | 18.34% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $714.33M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $779.56M | N/A | 46.70% | 46.70% | 28.34% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
